Loading clinical trials...
Loading clinical trials...
Evolocumab in Patients With Acute Myocardial Infarction: A Double-blind, Prospective, Randomized Placebo-Controlled Study
Conditions
Interventions
Evolocumab
Placebos
Locations
1
United States
The Johns Hopkins Hospital
Baltimore, Maryland, United States
Start Date
September 1, 2019
Primary Completion Date
October 25, 2024
Completion Date
October 25, 2024
Last Updated
October 23, 2025
NCT07436429
NCT07429227
NCT01311323
NCT06543082
NCT06535568
NCT07032389
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions